Pharma Packaging and Logistics
Pharma Packaging and Logistics
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility...
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has announced a significant expansion into a new innovation hub...
Pharma Packaging and Logistics
Delivery routes expanded and order cut-off times for midwest and west coast customers extended
Smith Drug Company, the industry's largest wholesaler dedicated exclusively to independent retail and long-term care pharmacies, has announced a series of operational enhancements designed...
Pharma Packaging and Logistics
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with...
Drug Discovery & Development
Samsung Biologics expands US manufacturing capacity with acquisition from GSK
Samsung Biologics has announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100% of Human...
Pharma Packaging and Logistics
Natix goes to China to enhance manufacturing
To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of...
Pharma Packaging and Logistics
Innovation to help US pharmacies ship confidently
Cold Chain Technologies (CCT), a global leader in temperature-controlled packaging, is transforming how specialty pharmacies manage cold chain logistics with its innovative digital applications...
Pharma Packaging and Logistics
Commercial supply enabled for breast cancer treatment drug
Enzene has announced the initiation of commercial supply of pertuzumab, a monoclonal antibody (mAb) therapy indicated for the treatment of HER2-positive (HER2+) breast cancer....
Pharma Packaging and Logistics
Denosumab biosimilars in bone-health and oncology now available to European patients
Stada has received marketing authorisations from the European Commission (EC) for its Kefdensis® and Zvogra® denosumab biosimilars.
These approvals for the same indications, route of administration and...
- Advertisement -
- Advertisement -
Latest stories
© 2026 Pharma Press Publishing.